BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24736807)

  • 1. The marine-derived sipholenol A-4-O-3',4'-dichlorobenzoate inhibits breast cancer growth and motility in vitro and in vivo through the suppression of Brk and FAK signaling.
    Akl MR; Foudah AI; Ebrahim HY; Meyer SA; El Sayed KA
    Mar Drugs; 2014 Apr; 12(4):2282-304. PubMed ID: 24736807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors.
    Foudah AI; Sallam AA; Akl MR; El Sayed KA
    Eur J Med Chem; 2014 Feb; 73():310-24. PubMed ID: 24487236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of marine triterpene sipholenols as inhibitors of breast cancer migration and invasion.
    Foudah AI; Jain S; Busnena BA; El Sayed KA
    ChemMedChem; 2013 Mar; 8(3):497-510. PubMed ID: 23404739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marine natural products-inspired phenylmethylene hydantoins with potent in vitro and in vivo antitumor activities via suppression of Brk and FAK signaling.
    Sallam AA; Mohyeldin MM; Foudah AI; Akl MR; Nazzal S; Meyer SA; Liu YY; El Sayed KA
    Org Biomol Chem; 2014 Jul; 12(28):5295-303. PubMed ID: 24927150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
    Shi Z; Jain S; Kim IW; Peng XX; Abraham I; Youssef DT; Fu LW; El Sayed K; Ambudkar SV; Chen ZS
    Cancer Sci; 2007 Sep; 98(9):1373-80. PubMed ID: 17640301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esters of the marine-derived triterpene sipholenol A reverse P-GP-mediated drug resistance.
    Zhang Y; Zhang YK; Wang YJ; Vispute SG; Jain S; Chen Y; Li J; Youssef DT; El Sayed KA; Chen ZS
    Mar Drugs; 2015 Apr; 13(4):2267-86. PubMed ID: 25874923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
    Abraham I; Jain S; Wu CP; Khanfar MA; Kuang Y; Dai CL; Shi Z; Chen X; Fu L; Ambudkar SV; El Sayed K; Chen ZS
    Biochem Pharmacol; 2010 Nov; 80(10):1497-506. PubMed ID: 20696137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.
    Wang S; Zhong Z; Wan J; Tan W; Wu G; Chen M; Wang Y
    Am J Chin Med; 2013; 41(1):177-96. PubMed ID: 23336515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cucurbitacin B suppresses metastasis mediated by reactive oxygen species (ROS) via focal adhesion kinase (FAK) in breast cancer MDA-MB-231 cells.
    Luo WW; Zhao WW; Lu JJ; Wang YT; Chen XP
    Chin J Nat Med; 2018 Jan; 16(1):10-19. PubMed ID: 29425586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative and antimetastatic properties of 3-benzyloxy-16-hydroxymethylene-estradiol analogs against breast cancer cell lines.
    Sinka I; Kiss A; Mernyák E; Wölfling J; Schneider G; Ocsovszki I; Kuo CY; Wang HC; Zupkó I
    Eur J Pharm Sci; 2018 Oct; 123():362-370. PubMed ID: 30010030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
    Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
    Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis.
    Sinha S; Khan S; Shukla S; Lakra AD; Kumar S; Das G; Maurya R; Meeran SM
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):41-56. PubMed ID: 27210504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The indole alkaloid meleagrin, from the olive tree endophytic fungus Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent breast cancer proliferation, migration and invasion.
    Mady MS; Mohyeldin MM; Ebrahim HY; Elsayed HE; Houssen WE; Haggag EG; Soliman RF; El Sayed KA
    Bioorg Med Chem; 2016 Jan; 24(2):113-22. PubMed ID: 26692349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New inhibitors of RANKL-induced Osteoclastogenesis from the marine sponge Siphonochalina siphonella.
    El-Beih AA; El-Desoky AH; Al-Hammady MA; Elshamy AI; Hegazy MF; Kato H; Tsukamoto S
    Fitoterapia; 2018 Jul; 128():43-49. PubMed ID: 29729401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery, optimization, and pharmacophore modeling of oleanolic acid and analogues as breast cancer cell migration and invasion inhibitors through targeting Brk/Paxillin/Rac1 axis.
    Elsayed HE; Akl MR; Ebrahim HY; Sallam AA; Haggag EG; Kamal AM; El Sayed KA
    Chem Biol Drug Des; 2015 Feb; 85(2):231-43. PubMed ID: 24954090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
    Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
    Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frondoside A inhibits human breast cancer cell survival, migration, invasion and the growth of breast tumor xenografts.
    Al Marzouqi N; Iratni R; Nemmar A; Arafat K; Ahmed Al Sultan M; Yasin J; Collin P; Mester J; Adrian TE; Attoub S
    Eur J Pharmacol; 2011 Oct; 668(1-2):25-34. PubMed ID: 21741966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aloperine inhibits proliferation, migration and invasion and induces apoptosis by blocking the Ras signaling pathway in human breast cancer cells.
    Tian D; Li Y; Li X; Tian Z
    Mol Med Rep; 2018 Oct; 18(4):3699-3710. PubMed ID: 30132540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pristimerin inhibits breast cancer cell migration by up- regulating regulator of G protein signaling 4 expression.
    Mu XM; Shi W; Sun LX; Li H; Wang YR; Jiang ZZ; Zhang LY
    Asian Pac J Cancer Prev; 2012; 13(4):1097-104. PubMed ID: 22799288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.